2017 Access Clinical Trials Medicine 
NORML
MAY 26, 2020
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.
Cannabis Law Report
NOVEMBER 29, 2019
Euractiv report… Germany’s regulatory approach to medical cannabis is good practice and should be replicated across Europe, according to newly-born European Medicinal Cannabis Association (EUMCA). Lack of clinical trials is a major reason why doctors are cautious about the drug.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
AUGUST 14, 2021
The deal signed in March had sought to progress an over-the-counter medicine with the TGA using Emyria’s EMD-003 program and Cann’s Gelpell technology. Cann Group (CAN) and Emyria (EMD) mutually agree to drop a deal for the proposed registration of a Schedule 3 cannabidiol (CBD) product.
The Cannigma
FEBRUARY 2, 2021
As medicinal cannabis treatments are now legal in many parts of the world, naturally, there is a growing interest in whether the products can treat neurological conditions like Parkinson’s disease. Patients can also access CBD products without a prescription through local pharmacies. Parkinson’s disease and cannabis.
Canna Care Docs
DECEMBER 11, 2018
It’s hard to get past decades of federal prohibition and criminalization, so it’s little wonder that in 2017 only three percent of adults over 65 years old reported being “current smokers.” [1]. Marijuana As Medicine. The above is just some of what’s becoming a very large body of evidence for cannabis as medicine. References.
Cannabis Law Report
MAY 29, 2022
In May 2021, a Nature Medicine study showed the benefits of MDMA in relieving post-traumatic stress disorder. [4] 4] In April 2021, a separate study from the New England Journal of Medicine demonstrated the efficacy of psilocybin in reducing symptoms of depression. [5] Clinical Trials and Human Subject Protections.
Cannabis Law Report
JULY 25, 2022
Psychedelics, medicine and ethics has always been a tricky thing and we’re suprised (or maybe not) that those who have held themselves up to be the paragons of perfection in the field over the past few years, have in fact been either arrogant, dumb or lazy when it comes to managing ethics at their organisations.
Expert insights. Personalized for you.
239 
Let's personalize your content